148 related articles for article (PubMed ID: 29427367)
1. Effects of Biorelevant Media Components on Dissolution Behaviour of 1,2,4-Thiadiazole Derivative Designed for Alzheimer's Disease Prevention.
Promzeleva M; Chislov M; Volkova T; Proshin A; Kumeev R; Terekhova I
Chem Biodivers; 2018 Feb; 15(2):. PubMed ID: 29427367
[TBL] [Abstract][Full Text] [Related]
2. Improved Biopharmaceutical Properties of Oral Formulations of 1,2,4-Thiadiazole Derivative with Cyclodextrins: in Vitro and in Vivo Evaluation.
Promzeleva M; Volkova T; Proshin A; Siluykov O; Mazur A; Tolstoy P; Ivanov S; Kamilov F; Terekhova I
ACS Biomater Sci Eng; 2018 Feb; 4(2):491-501. PubMed ID: 33418739
[TBL] [Abstract][Full Text] [Related]
3. Advances in the design of fasted state simulating intestinal fluids: FaSSIF-V3.
Fuchs A; Leigh M; Kloefer B; Dressman JB
Eur J Pharm Biopharm; 2015 Aug; 94():229-40. PubMed ID: 26032292
[TBL] [Abstract][Full Text] [Related]
4. Prediction of in vitro drug dissolution into fasted-state biorelevant media: Contributions of solubility enhancement and relatively low colloid diffusivity.
Jamil R; Polli JE
Eur J Pharm Sci; 2022 Jul; 174():106210. PubMed ID: 35577180
[TBL] [Abstract][Full Text] [Related]
5. Importance of critical micellar concentration for the prediction of solubility enhancement in biorelevant media.
Ottaviani G; Wendelspiess S; Alvarez-Sánchez R
Mol Pharm; 2015 Apr; 12(4):1171-9. PubMed ID: 25665011
[TBL] [Abstract][Full Text] [Related]
6. Prediction of food effect on in vitro drug dissolution into biorelevant media: Contributions of solubility enhancement and relatively low colloid diffusivity.
Jamil R; Polli JE
Eur J Pharm Sci; 2022 Oct; 177():106274. PubMed ID: 35944878
[TBL] [Abstract][Full Text] [Related]
7. Biorelevant dissolution media as a predictive tool for glyburide a class II drug.
Wei H; Löbenberg R
Eur J Pharm Sci; 2006 Sep; 29(1):45-52. PubMed ID: 16815694
[TBL] [Abstract][Full Text] [Related]
8. Integration of Biorelevant Pediatric Dissolution Methodology into PBPK Modeling to Predict In Vivo Performance and Bioequivalence of Generic Drugs in Pediatric Populations: a Carbamazepine Case Study.
Pawar G; Wu F; Zhao L; Fang L; Burckart GJ; Feng K; Mousa YM; Al Shoyaib A; Jones MC; Batchelor HK
AAPS J; 2023 Jun; 25(4):67. PubMed ID: 37386339
[TBL] [Abstract][Full Text] [Related]
9. Impact of sodium dodecyl sulphate on the dissolution of poorly soluble drug into biorelevant medium from drug-surfactant discs.
Madelung P; Ostergaard J; Bertelsen P; Jørgensen EV; Jacobsen J; Müllertz A
Int J Pharm; 2014 Jun; 467(1-2):1-8. PubMed ID: 24594297
[TBL] [Abstract][Full Text] [Related]
10. Dissolution media simulating the proximal canine gastrointestinal tract in the fasted state.
Arndt M; Chokshi H; Tang K; Parrott NJ; Reppas C; Dressman JB
Eur J Pharm Biopharm; 2013 Aug; 84(3):633-41. PubMed ID: 23434923
[TBL] [Abstract][Full Text] [Related]
11. The impact of reduced gastric acid secretion on dissolution of salts of weak bases in the fasted upper gastrointestinal lumen: Data in biorelevant media and in human aspirates.
Litou C; Vertzoni M; Xu W; Kesisoglou F; Reppas C
Eur J Pharm Biopharm; 2017 Jun; 115():94-101. PubMed ID: 28214603
[TBL] [Abstract][Full Text] [Related]
12. Use of conventional surfactant media as surrogates for FaSSIF in simulating in vivo dissolution of BCS class II drugs.
Lehto P; Kortejärvi H; Liimatainen A; Ojala K; Kangas H; Hirvonen J; Tanninen VP; Peltonen L
Eur J Pharm Biopharm; 2011 Aug; 78(3):531-8. PubMed ID: 21329757
[TBL] [Abstract][Full Text] [Related]
13. Surface Dissolution UV Imaging for Investigation of Dissolution of Poorly Soluble Drugs and Their Amorphous Formulation.
Long CM; Tang K; Chokshi H; Fotaki N
AAPS PharmSciTech; 2019 Feb; 20(3):113. PubMed ID: 30761437
[TBL] [Abstract][Full Text] [Related]
14. Interaction between fed gastric media (Ensure Plus®) and different hypromellose based caffeine controlled release tablets: comparison and mechanistic study of caffeine release in fed and fasted media versus water using the USP dissolution apparatus 3.
Franek F; Holm P; Larsen F; Steffansen B
Int J Pharm; 2014 Jan; 461(1-2):419-26. PubMed ID: 24342711
[TBL] [Abstract][Full Text] [Related]
15. Investigation of solubilising effects of bile salts on an active pharmaceutical ingredient with unusual pH dependent solubility by NMR spectroscopy.
Vogtherr M; Marx A; Mieden AC; Saal C
Eur J Pharm Biopharm; 2015 May; 92():32-41. PubMed ID: 25720817
[TBL] [Abstract][Full Text] [Related]
16. Similarity of dissolution profiles from biorelevant media: Assessment of interday repeatability, interanalyst repeatability, and interlaboratory reproducibility using ibuprofen and ketoconazole tablets.
Jamil R; Xu T; Shah HS; Adhikari A; Sardhara R; Nahar K; Morris KR; Polli JE
Eur J Pharm Sci; 2021 Jan; 156():105573. PubMed ID: 32987114
[TBL] [Abstract][Full Text] [Related]
17. Dynamic dissolution testing to establish in vitro/in vivo correlations for montelukast sodium, a poorly soluble drug.
Okumu A; DiMaso M; Löbenberg R
Pharm Res; 2008 Dec; 25(12):2778-85. PubMed ID: 18560996
[TBL] [Abstract][Full Text] [Related]
18. Efficiency of single pharmaceutical surfactants to mimic intestinal biorelevant media solubilization and dissolution of etravirine: Comparison of intrinsic and film dissolution models.
Oktay AN; Polli JE
Eur J Pharm Sci; 2024 May; 196():106746. PubMed ID: 38499112
[TBL] [Abstract][Full Text] [Related]
19. Biorelevant Drug Solubility Enhancement Modeled by a Linear Solvation Energy Relationship.
Niederquell A; Kuentz M
J Pharm Sci; 2018 Jan; 107(1):503-506. PubMed ID: 28864357
[TBL] [Abstract][Full Text] [Related]
20. Dissolution rate and apparent solubility of poorly soluble drugs in biorelevant dissolution media.
Fagerberg JH; Tsinman O; Sun N; Tsinman K; Avdeef A; Bergström CA
Mol Pharm; 2010 Oct; 7(5):1419-30. PubMed ID: 20507160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
